XIL Health CEO and Founder, Susan Lang, Makes Inc.’s 2022 Female Founders 100 List ST. LOUIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- XIL Health, a leading strategic technology and analytics company in the drug economic space, today announces that its CEO and founder, Susan Lang, has...

XIL Health Ranks No. 945 on the 2022 Inc. 5000 List, Experiencing Rapid Growth with XIL Impact Expansion ST. LOUIS, Aug. 16, 2022 (GLOBE NEWSWIRE) -- XIL Health, a leading strategic analytics and technology company in the drug space, today announces its ranking on Inc. Magazine’s annual Inc. 5000 list...

XIL Health Develops Interactive Vaccine Dashboard with COVID Tracker for Pharmacies Nationwide ST. LOUIS, Feb. 15, 2022 (GLOBE NEWSWIRE) -- XIL Health, a leading strategic analytics and technology company in the drug economics space that built the XIL Impact SaaS platform, today announces its...

XIL Health’s VP of Client Growth & Innovation Recognized as an OBJ 2021 Power Player for Industry Disruption LAKE NONA, Fla., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Alexandra Robertson, XIL Health’s Vice President of Client Growth & Innovation, has been named an Orlando Business Journal 2021 Power Player...

XIL Health Announces XIL Impact, Offering Pharmacy Executives Complete Look at Finances, Analytics, Insights to Negotiate Drug Reimbursements in Contentious Marketplace ST. LOUIS, June 01, 2021 (GLOBE NEWSWIRE) -- XIL Health, a leading strategic analytics and technology company in the drug economics space, announces its latest technology suite, XIL Impact – a...